Advertisement

The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

Presenter: Roxana Mehran

October 15, 2020

REGISTER for free or LOG IN to view this content

The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients

Up Next

Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients

Presenter: Michel Bosiers

October 15, 2020

More slides +

Keynote Lecture: Key Advances in RDN for HTN

Presenter: Felix Mahfoud

October 15, 2020

Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

Presenter: Junjie Zhang

October 15, 2020

Presentation

TCT 2020

DAPT

Stent

XIENCE

Roxana Mehran

Country